Latest Period
Q2 2026
Security Snapshot
NRC HEALTH - Common Stock (NRC) Institutional Ownership
CUSIP: 637372202
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
121
Shares (Excl. Options)
10,751,911
Price
$21.57
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- NRC on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 10,751,911
- Total 13F value
- $231,880,167
- Portfolio coverage rank
- 0%
- Share change
- -75,165
- Value change
- -$937,552
- Number of holders
- 121
- Shares outstanding
- 22,561,022
- SEC-reported price per share
- $21.66
- Insider filing price
- $21.66
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NRC - NRC HEALTH - Common Stock is tracked under CUSIP 637372202.
- 121 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 119 to 121 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $184,219,586 to $231,880,167.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 121 institutions filings for Q2 2026.
Security key
637372202
Latest holder period
Q2 2026
13F holders
121
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
NRC full holder history
NRC HEALTH SEC filings
NRC HEALTH company facts
NRC HEALTH insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 637372202:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
NRC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Common Property Trust | 46% | -0.87% | $173,546,877 | -$4,715,705 | 10,305,634 | -2.6% | Beans Patrick E. | 10 Jun 2026 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 9% | -22% | $44,325,640 | -$13,694,832 | 2,030,492 | -24% | Kayne Anderson Rudnick Investment Management, LLC | 30 Jun 2026 |
| BlackRock, Inc. | 4.4% | -14% | $10,850,303 | -$2,050,837 | 1,014,047 | -16% | BlackRock, Inc. | 31 Mar 2025 |
As of 30 Jun 2026, 121 institutional investors reported holding 10,751,911 shares of NRC HEALTH - Common Stock (NRC). This represents 48% of the company’s total 22,561,022 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
42%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 9% | 2,030,492 | -23% | 0.14% | $43,797,714 |
| BlackRock, Inc. | 4.7% | 1,061,355 | +8.8% | 0% | $22,893,428 |
| MORGAN STANLEY | 3.8% | 859,268 | -14% | 0% | $18,534,426 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3% | 666,554 | +0.56% | 0% | $14,377,570 |
| DIMENSIONAL FUND ADVISORS LP | 2.2% | 491,228 | +0.3% | 0% | $10,595,956 |
| Willis Investment Counsel | 1.9% | 434,785 | +94% | 0.45% | $9,378,312 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 420,056 | +6.7% | 0% | $9,062,880 |
| QV Investors Inc. | 1.7% | 372,503 | -2.3% | 0.62% | $8,035,000 |
| FARMERS & MERCHANTS INVESTMENTS INC | 1.5% | 330,649 | +330549% | 0.17% | $7,132,099 |
| RENAISSANCE TECHNOLOGIES LLC | 1.4% | 325,384 | -4.5% | 0.01% | $7,018,533 |
| HEARTLAND ADVISORS INC | 1.3% | 300,000 | +27% | 0.29% | $6,471,000 |
| STATE STREET CORP | 1.3% | 298,384 | -0.79% | 0% | $6,483,381 |
| Bank of New York Mellon Corp | 1.1% | 252,235 | +0.61% | 0% | $5,440,710 |
| NORTHERN TRUST CORP | 1.1% | 238,243 | -6.8% | 0% | $5,138,900 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 0.83% | 187,920 | -34% | 0.01% | $4,053,434 |
| iA Global Asset Management Inc. | 0.83% | 187,520 | 0% | 0.05% | $4,045,000 |
| WELLS FARGO & COMPANY/MN | 0.8% | 179,623 | +54% | 0% | $3,874,460 |
| AQR CAPITAL MANAGEMENT LLC | 0.54% | 122,206 | -29% | 0% | $2,635,976 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.5% | 113,312 | +0.83% | 0% | $2,444,140 |
| Northwest & Ethical Investments L.P. | 0.45% | 102,370 | -21% | 0.05% | $2,208,121 |
| VANGUARD FIDUCIARY TRUST CO | 0.43% | 97,200 | +4.3% | 0% | $2,096,604 |
| GOLDMAN SACHS GROUP INC | 0.43% | 96,776 | +17% | 0% | $2,087,458 |
| JANE STREET GROUP, LLC | 0.39% | 87,375 | +24% | 0% | $1,884,679 |
| FIFTH THIRD BANCORP | 0.38% | 85,372 | -5.3% | 0% | $1,841,475 |
| BANK OF AMERICA CORP /DE/ | 0.37% | 82,946 | -26% | 0% | $1,789,145 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 10,751,911 | $231,880,167 | -$937,552 | $21.57 | 121 |
| 2026 Q1 | 10,844,286 | $184,219,586 | +$3,115,994 | $16.98 | 119 |
| 2025 Q4 | 10,745,800 | $201,606,565 | -$5,605,734 | $18.77 | 116 |
| 2025 Q3 | 11,109,644 | $142,023,248 | -$7,941,184 | $12.78 | 116 |
| 2025 Q2 | 11,671,181 | $196,114,843 | +$3,893,782 | $16.80 | 124 |
| 2025 Q1 | 11,503,564 | $147,284,867 | -$6,206,822 | $12.80 | 122 |
| 2024 Q4 | 11,878,871 | $209,583,639 | -$2,343,384 | $17.64 | 132 |
| 2024 Q3 | 11,934,034 | $272,840,522 | -$6,927,729 | $22.86 | 137 |
| 2024 Q2 | 12,182,341 | $279,622,437 | -$21,335,705 | $22.95 | 132 |
| 2024 Q1 | 12,745,050 | $505,224,889 | +$28,006,688 | $39.61 | 141 |
| 2023 Q4 | 12,021,040 | $475,597,179 | -$3,757,713 | $39.56 | 129 |
| 2023 Q3 | 12,126,634 | $538,449,269 | +$20,270,452 | $44.37 | 120 |
| 2023 Q2 | 11,662,652 | $507,799,722 | +$9,048,952 | $43.51 | 115 |
| 2023 Q1 | 11,452,078 | $498,653,789 | -$4,356,439 | $43.51 | 123 |
| 2022 Q4 | 11,704,412 | $437,476,387 | +$36,764,570 | $37.30 | 115 |
| 2022 Q3 | 11,675,608 | $464,909,449 | +$5,806,059 | $39.80 | 109 |
| 2022 Q2 | 11,521,526 | $440,979,718 | +$947,742 | $38.28 | 108 |
| 2022 Q1 | 11,507,618 | $456,280,796 | +$3,529,770 | $39.65 | 114 |
| 2021 Q4 | 11,416,748 | $473,681,626 | +$4,397,518 | $41.52 | 111 |
| 2021 Q3 | 11,228,351 | $473,712,379 | +$2,204,108 | $42.17 | 108 |
| 2021 Q2 | 11,179,409 | $514,210,467 | +$12,286,535 | $45.90 | 100 |
| 2021 Q1 | 10,907,137 | $511,278,633 | +$5,950,900 | $46.83 | 96 |
| 2020 Q4 | 10,781,336 | $461,751,144 | +$8,374,142 | $42.75 | 90 |
| 2020 Q3 | 10,532,859 | $519,036,815 | -$2,532,454 | $49.21 | 91 |
| 2020 Q2 | 10,514,023 | $612,184,938 | +$22,527,414 | $58.21 | 93 |